Ani pharmaceuticals, inc. closes $316.25 million convertible senior notes offering including full exercise of initial purchasers' option to purchase additional notes

Princeton, n.j., aug. 13, 2024 (globe newswire) -- ani pharmaceuticals, inc. (ani or the company) (nasdaq: anip) today announced the closing of its offering of $316,250,000 aggregate principal amount of 2.25% convertible senior notes due 2029 (the “notes”) in a private offering to qualified institutional buyers pursuant to rule 144a under the securities act of 1933, as amended (the “securities act”). in response to investor demand, ani upsized the initial offering of $250,000,000 aggregate principal amount of notes to $275,000,000 and the initial purchasers fully exercised their option to purchase an additional $41,250,000 aggregate principal amount of the notes. the notes were issued pursuant to, and are governed by, an indenture, dated as of august 13, 2024, between the company and u.s. bank trust company, national association, as trustee.
ANIP Ratings Summary
ANIP Quant Ranking